Chitosan‐Coated Edaravone‐N‐Benzyl Pyridium Hybrid Polycaprolactone/ Poloxamer 188 Nanoparticles for Enhanced Alzheimer's Disease Drug Delivery
In conclusion, NPs were successfully synthesized and characterized, demonstrating stability, efficient EBPD encapsulation, and potential for BBB permeation. Future studies will evaluate drug release, loading efficiency, cytotoxicity, and BBB permeability using bend5 cells to validate their therapeutic potential for AD treatment.
Authors
- Teboho E. Tutubala
- Dubelab UWC Pharm Chem
Institutions
- Health & Medical Publishing Group (ZA)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_106679
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00